Charles P France

Professor, Pharmacology

Phone+1-210-567-6969
Emailfrance@uthscsa.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Charles P France is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

8 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

2 Not started
11 Finished

A novel opioid receptor antagonist for treating abuse and overdose
France, C. P.
Project: Research project
Repurposing drugs in mixtures to treat drug abuse
France, C. P.
Project: Research project
Evaluation of the 5-HT2C agonist lorcaserin as potential treatment for cocaine ab
France, C. P.
National Institutes of Health
5/1/13 → 4/30/16
Project: Research project
Training in Drug Abuse Research: Behavior and Neurobiology
France, C. P.
National Institutes of Health
7/1/11 → 6/30/16
Project: Research project
Delay discounting: effects of drug dependence and withdrawal
France, C. P.
National Institutes of Health
7/15/10 → 6/30/16
Project: Research project

4591 Citations
34 h-Index
242 Article
9 Conference contribution
9 Review article
4 Chapter
More
- 2 Comment/debate
- 1 Editorial

Discriminative stimulus effects of carfentanil in rats discriminating fentanyl: Differential antagonism by naltrexone
Flynn, S. M. & France, C. P., Apr 1 2021, In: Drug and Alcohol Dependence. 221, 108599.
Research output: Contribution to journal › Article › peer-review
Methocinnamox reverses and prevents fentanyl-induced ventilatory depression in rats
Jimenez, V. M., Castaneda, G. & France, C. P., Apr 1 2021, In: Journal of Pharmacology and Experimental Therapeutics. 377, 1, p. 29-38 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Behavioral effects of benzylideneoxymorphone (BOM), a low efficacy µ opioid receptor agonist and a δ opioid receptor antagonist
Mada, S., Gerak, L. R., Soyer, A., Maguire, D. R., Hu, Z., Minervini, V., Cunningham, C. W. & France, C. P., Dec 2020, In: Psychopharmacology. 237, 12, p. 3591-3602 12 p.
Research output: Contribution to journal › Article › peer-review
Behavioral pharmacology of drugs acting at mu opioid receptors
Gerak, L. R., Maguire, D. R. & France, C. P., 2020, Handbook of Experimental Pharmacology. Springer, p. 127-145 19 p. (Handbook of Experimental Pharmacology; vol. 258).
Research output: Chapter in Book/Report/Conference proceeding › Chapter
2 Scopus citations
Countermeasures for Preventing and Treating Opioid Overdose
France, C. P., Ahern, G. P., Averick, S., Disney, A., Enright, H. A., Esmaeli-Azad, B., Federico, A., Gerak, L. R., Husbands, S. M., Kolber, B., Lau, E. Y., Lao, V., Maguire, D. R., Malfatti, M. A., Martinez, G., Mayer, B. P., Pravetoni, M., Sahibzada, N., Skolnick, P., Snyder, E. Y. & 3 others, Tomycz, N., Valdez, C. A. & Zapf, J., 2020, (Accepted/In press) In: Clinical Pharmacology and Therapeutics.
Research output: Contribution to journal › Review article › peer-review
2 Scopus citations

House Energy and Commerce Subcommittee on Health Hearing; "An Epidemic within a Pandemic: Understanding Substance Use and Misuse in America."; Testimony by Geoffrey Laredo, Principal, Santa Cruz Strategies, LLC.
Charles P France
4/14/21
1 item of Media coverage
Press/Media: Press / Media
Open letter on the economic impacts of the EU-Mercosur agreement
Charles P France
11/10/20
1 item of Media coverage
Press/Media: Press / Media
Allen E. Peterson
Charles P France
8/25/20
1 item of Media coverage
Press/Media: Press / Media
Long-lasting treatment drug could slow the opioid crisis
Martin A Javors, William P Clarke, Charles P France, Kelly A Berg, David R Maguire & James H Woods
3/8/20
1 item of Media coverage
Press/Media: Press / Media
New drug blocks the fatal effects of opioids?
Charles P France
3/6/20
1 item of Media coverage
Press/Media: Press / Media